{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:21:37Z","timestamp":1770063697510,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T00:00:00Z","timestamp":1219017600000},"content-version":"vor","delay-in-days":3121,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background<\/jats:italic>: There is compelling evidence for the pivotal role of <jats:italic>Helicobacter pylori<\/jats:italic> in the pathogenesis of gastrointestinal ulcer disease. However, despite the bacterium's toxicity, the majority of <jats:italic>H. pylori<\/jats:italic> infections are not accompanied by gastric ulcers. This implies the existence of a host mechanism offsetting <jats:italic>H. pylori<\/jats:italic> toxicity.<\/jats:p><jats:p> <jats:italic>Aims<\/jats:italic>: To evaluate gastric fibroblasts' expression of hepatocyte growth factor (HGF), which is known to facilitate gastric ulcer healing, in the presence of <jats:italic>H. pylori;<\/jats:italic> to compare the effect on <jats:italic>H. pylori<\/jats:italic>\u2010induced HGF expression of a COX\u20102 selective inhibitor with that of nonselective nonsteroidal anti\u2010inflammatory drugs (NSAIDs).<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: Human gastric fibroblasts were cultured from human gastric mucosa obtained at surgery. Prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) and HGF were measured by EIA. The expression of COX\u20102 mRNA was assessed by the TaqMan quantitative RT\u2010PCR system.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: <jats:italic>H. pylori<\/jats:italic> increased PGE<jats:sub>2<\/jats:sub> release in gastric fibroblasts. <jats:italic>H. pylori<\/jats:italic> induced expression of COX\u20102 mRNA, which indicates that PG induction by <jats:italic>H. pylori<\/jats:italic> is through COX\u20102. Sulindac sulphide, etodolac and NS 398 all inhibited <jats:italic>H. pylori<\/jats:italic>\u2010induced PGE<jats:sub>2<\/jats:sub> release to the same extent. These agents also inhibited <jats:italic>H. pylori<\/jats:italic>\u2010induced HGF release.<\/jats:p><jats:p> <jats:italic>Conclusion<\/jats:italic>: Gastric fibroblasts produce PG and HGF in response to the presence of <jats:italic>H. pylori<\/jats:italic>, which may be considered part of the human body's defensive reaction to <jats:italic>H. pylori<\/jats:italic> toxicity. This defensive mechanism is inhibited not only by COX\u20102 nonselective NSAIDs but also by a COX\u20102 selective inhibitor. These findings indicate the importance of COX\u20102 in chronic <jats:italic>H. pylori<\/jats:italic> infection.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2000.014s1044.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:42:17Z","timestamp":1047354137000},"page":"44-49","source":"Crossref","is-referenced-by-count":19,"title":["The effect of NSAIDs and a COX\u20102 specific inhibitor on Helicobacter pylori\u2010induced PGE<sub>2<\/sub> and HGF in human gastric fibroblasts"],"prefix":"10.1111","volume":"14","author":[{"given":"M.","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Terano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(79)90235-X"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3228"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.12013"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9024292"},{"key":"e_1_2_6_6_2","first-page":"21","article-title":"Prostaglandin and protection of the gastroduodenal mucosa","volume":"77","author":"Johansson C","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_7_2","first-page":"G514","article-title":"Topical effects of 16,16\u2010dimethyl prostaglandin E2 on gastric blood flow in dogs","volume":"238","author":"Cheung LY","year":"1980","journal-title":"Am J Physiol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6828859"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119080"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1250"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117884"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0178"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501193320302"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90929-4"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.5.1653"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5791"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7276"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8600"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-7658-7_10"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.014s1044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.014s1044.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.014s1044.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T13:37:48Z","timestamp":1695735468000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.014s1044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":18,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2036.2000.014s1044.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.014s1044.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}